Pancreatic cancer screening for families with a history of the disease may lead to earlier detection, but the problem is knowing which tests are best and which people to give them to, according to researchers at New York's Memorial Sloan-Kettering Cancer Center. Large-scale trials are needed as only a few patients out of each 100 have the familial form of the disease. Screening is also expensive and is not widely available, according to the report in the American Journal of Gastroenterology. Read the abstract.
Published in Brief: